⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4495963 | 0.76 | NPC1 (0.42) | — | |
| SCHEMBL4493865 | 0.73 | MAPT (0.46) | — | |
| SCHEMBL12672192 | 0.69 | EPHX2 (0.42) | — | |
| SCHEMBL449770 | 0.67 | PLAU (0.42) | — | |
| SCHEMBL30271877 | 0.67 | ALOX15 (0.43) | — | |
| SCHEMBL28751195 | 0.67 | ALOX15 (0.39) | — | |
| SCHEMBL446852 | 0.67 | NPC1 (0.34) | — | |
| SCHEMBL4505185 | 0.67 | ALOX15 (0.43) | — | |
| SCHEMBL17349231 | 0.66 | ACHE (0.38) | — | |
| SCHEMBL449771 | 0.65 | NPC1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313535-A1 | ALPHA 4 BETA 7 INTEGRIN MODULATORS AND USES THEREOF | DICE MOLECULES SV, INC. | 2025-10-09 | — | — | US | claimed |
| EP-4522589-A1 | ALPHA 4 BETA 7 INTEGRIN MODULATORS AND USES THEREOF | Dice Molecules Sv, Inc. (US) | 2025-03-19 | — | — | EP | claimed |
| CN-119562944-A | Alpha 4 beta 7 integrin modulators and uses thereof | 戴斯分子SV有限公司 | 2025-03-04 | — | — | CN | claimed |
| WO-2023220741-A1 | ALPHA 4 BETA 7 INTEGRIN MODULATORS AND USES THEREOF | DICE MOLECULES SV, INC. (US) | 2023-11-16 | — | — | WO | claimed |
| US-7285553-B2 | Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders | ALCON MANUFACTURING, LTD. (US) | 2007-10-23 | — | — | US | claimed |
| US-20260092053-A1 | KHK INHIBITORS | GILEAD SCIENCES INC (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4681774-A2 | KHK INHIBITORS | Gilead Sciences, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| EP-4665737-A1 | PHOSPHOLIPID COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. (US) | 2025-12-24 | — | — | EP | disclosed |
| US-20250361236-A9 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | GILEAD SCIENCES INC (US) | 2025-11-27 | — | — | US | disclosed |
| EP-4313967-B1 | KHK INHIBITORS | GILEAD SCIENCES INC (US) | 2025-11-12 | — | — | EP | disclosed |
| US-20250313535-A1 | ALPHA 4 BETA 7 INTEGRIN MODULATORS AND USES THEREOF | DICE MOLECULES SV, INC. | 2025-10-09 | — | — | US | disclosed |
| US-12410160-B2 | KHK inhibitors | GILEAD SCIENCES, INC. (US) | 2025-09-09 | — | — | US | disclosed |
| US-20050197362-A1 | Preventives/remedies for urinary disturbance | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-09-08 | — | — | US | disclosed |
| US-20050053871-A1 | Novel surfactants for use in substantially light-insensitive thermographic recording materials | AGFA-GEVAERT N.V. (BE) | 2005-03-10 | — | — | US | disclosed |
| CN-1589153-A | Prevention or treatment of urinary disorders | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2005-03-02 | — | — | CN | disclosed |
| EP-1466625-A1 | PREVENTIVES/REMEDIES FOR URINARY DISTURBANCE | Takeda Chemical Industries, Ltd. (JP) | 2004-10-13 | — | — | EP | disclosed |
| EP-1311264-A1 | SUBSTITUTED AND NON-SUBSTITUTED BENZOOXATHIAZOLES AND COMPOUNDS DERIVED THEREFROM | Aventis Pharma Deutschland GmbH (DE) | 2003-05-21 | — | — | EP | disclosed |
| WO-2002011722-A1 | SUBSTITUTED AND NON-SUBSTITUTED BENZOOXATHIAZOLES AND COMPOUNDS DERIVED THEREFROM | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-02-14 | — | — | WO | disclosed |
| US-4031227-A | CNS DEPRESSANT AGENTS, SLEEP INDUCERS, TRANQUILIZERS | SANDOZ, INC. (US) | 1977-06-21 | — | — | US | disclosed |
| US-4031227-A | CNS DEPRESSANT AGENTS, SLEEP INDUCERS, TRANQUILIZERS | SANDOZ, INC. (US) | 1977-06-21 | — | — | US | disclosed |